Literature DB >> 32590224

Equus caballus papillomavirus type 2 (EcPV2) in co-occurring vulvar and gastric lesions of a pony.

Ilaria Porcellato1, Paola Modesto2, Katia Cappelli3, Katia Varello2, Simone Peletto2, Chiara Brachelente3, Isabella Martini2, Luca Mechelli3, Angelo Ferrari2, Alessandro Ghelardi4, Elisabetta Razzuoli2.   

Abstract

In horses, squamous cell carcinomas (SCCs) are the most common malignant tumors developing on non-pigmented skin, muco-cutaneous areas, like external genitalia, and, less frequently, in the stomach. Growing evidence suggests Equus caballus papillomavirus type 2 (EcPV2) as causative agent of genital SCCs. Our case report describes a 20-year-old, female, mixed-breed pony with co-occurring vulvar papilloma and in situ carcinoma and gastric SCC. Both lesions were positive for the same EcPV2, as confirmed by DNA sequencing. E6 mRNA expression was observed both in vulvar lesions and gastric SCC, while L1 mRNA was expressed in the vulvar tumor. To the best of the Authors' knowledge, this is the first report of an association between EcPV2 and equine gastric squamous cell carcinoma, with co-occurring EcPV2-positive genital lesions. Further studies are required to assess the real prevalence and the possible role of this viral type in these equine tumors.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carcinoma; EcPV2; Horse; Papilloma; Squamous cell; Stomach; Vulva

Year:  2020        PMID: 32590224     DOI: 10.1016/j.rvsc.2020.06.003

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  6 in total

1.  Epithelial to Mesenchymal Transition (EMT) in a Laryngeal Squamous Cell Carcinoma of a Horse: Future Perspectives.

Authors:  Federico Armando; Francesco Godizzi; Elisabetta Razzuoli; Fabio Leonardi; Mario Angelone; Attilio Corradi; Daniela Meloni; Luca Ferrari; Benedetta Passeri
Journal:  Animals (Basel)       Date:  2020-12-07       Impact factor: 2.752

Review 2.  Equine Squamous Gastric Disease: Prevalence, Impact and Management.

Authors:  Michael Hewetson; Rose Tallon
Journal:  Vet Med (Auckl)       Date:  2021-12-31

3.  Detection of Equus Caballus Papillomavirus Type-2 in Asymptomatic Italian Horses.

Authors:  Katia Cappelli; Chiara Grazia De Ciucis; Samanta Mecocci; Tiziana Nervo; Maria Ines Crescio; Marco Pepe; Rodolfo Gialletti; Daniele Pietrucci; Laura Federica Migone; Silvia Turco; Luca Mechelli; Fabrizio Passamonti; Carlo Drago; Gian Guido Donato; Katia Varello; Paola Modesto; Giovanni Chillemi; Alessandro Ghelardi; Elisabetta Razzuoli
Journal:  Viruses       Date:  2022-07-31       Impact factor: 5.818

4.  Equus caballus Papillomavirus Type-9 (EcPV9): First Detection in Asymptomatic Italian Horses.

Authors:  Livia De Paolis; Chiara Grazia De Ciucis; Simone Peletto; Katia Cappelli; Samanta Mecocci; Tiziana Nervo; Lisa Guardone; Maria Ines Crescio; Daniele Pietrucci; Floriana Fruscione; Federica Gabbianelli; Silvia Turco; Katia Varello; Gian Guido Donato; Cristiana Maurella; Paola Modesto; Maria Grazia Maniaci; Giovanni Chillemi; Alessandro Ghelardi; Elisabetta Razzuoli
Journal:  Viruses       Date:  2022-09-15       Impact factor: 5.818

5.  Equine Penile Squamous Cell Carcinomas as a Model for Human Disease: A Preliminary Investigation on Tumor Immune Microenvironment.

Authors:  Ilaria Porcellato; Samanta Mecocci; Luca Mechelli; Katia Cappelli; Chiara Brachelente; Marco Pepe; Margherita Orlandi; Rodolfo Gialletti; Benedetta Passeri; Angelo Ferrari; Paola Modesto; Alessandro Ghelardi; Elisabetta Razzuoli
Journal:  Cells       Date:  2020-10-27       Impact factor: 6.600

6.  Equine Genital Squamous Cell Carcinoma Associated with EcPV2 Infection: RANKL Pathway Correlated to Inflammation and Wnt Signaling Activation.

Authors:  Samanta Mecocci; Ilaria Porcellato; Federico Armando; Luca Mechelli; Chiara Brachelente; Marco Pepe; Rodolfo Gialletti; Benedetta Passeri; Paola Modesto; Alessandro Ghelardi; Katia Cappelli; Elisabetta Razzuoli
Journal:  Biology (Basel)       Date:  2021-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.